Fogorvosi szemle, 2002 (95. évfolyam, 1-6. szám)

2002-02-01 / 1. szám

FOGORVOSI SZEMLE

95. évf. 1. sz. 2002.

19

Irodalom

1. Adams D, Davis G: Gingival hyperplasia associated with Cyclosporin-A. Br Dent J 1984; 57: 89-90.

2. Allman SD, McWhorter AG, Seale NS: Evaluation of cyclosporin-induced gingival overgrowth in the pediatric transplant patient. Pediatr DenM 994; 16: 36-40.

3. Baden E: Sodium dilantin gingival hyperplasia and conservative treatment: A case report. J Dent Med 1950; 5: 46-48.

4. Bader G, Lejeune S, Messner M: Reduction of cyclosporin-induced gingival overgrowth following change to tarcolymous. A case history involving a liver transplant patient. J Periodontot 1998; 69: 729-732.

5. Barthold PM: Regulation of human gingival fibroblast growth and synthetic activity by cyclosporin-A in vitro. J Periodont Res 1989; 24: 314-321.

6. Britton S, Palacios R: Cyclosporin-A - usefulness, risks and mechanism of action. Immunol Rev 1982; 65: 5-22.

7. BusqueS, Dermes P, StLouis G, étal: Conversion from Neoral (cyclosporine) to tarcolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplat Proc 1998; 30: 1247-1248.

8. Butler RT, Kalkwarf KL, Kaldhal WB: Drug-induced gingival hyperplasia: Phenitoin, cyclosporin and nifedipine. J Am Dent Assoc 1987; 114: 56-60.

9. Calnery: Cyclosporin-A in clinical organ grafting. Transpl Proc 1981; 13: 349-358.

10. CiANCiO SG, Bratz NW, Lauciello FR: Cyclosporine-induced gingival hyperplasia and clorhexidine: A case report. Int J Period Rest Dentt 991; 3: 241-245.

11. Coley C, Jarvis K, Hassel T: Effect of cyclosporin-A on human gingival fibroblasts in vitro. J Dent Res 1986; (Spec Issue): 353 (Abstr.1658).

12. Daley TD, Wysocki GP, Day CD: Clinical and pharmacological correlation in cyclosporin-induced gingival hyperplasia. Oral Surg Oral Med Oral Path 1986; 62: 417-421.

13. Daley TD, Wysocki GP: Cyclosporin therapy: its significance to the periodontits. J Periodontol 1984; 55: 708-712.

14. Evans db, Henderson R, Hamilton DC, Boone N, McMaster P, Gibly O, Wilhiams R: Cyclosporin-A in clinical organ grafting. Transpl Proc 1981 ; 13: 349-358.

15. Fan XF, Scott PG: Cyclosporine effects on gingival fibroblasts in vitro. J Dent Res 1989; 68: (Spec. Issue) 288 (Abstr.854).

16. Fu E, NielS, Wikesjo ME, Fu-Gong L, Shen E: Gingival overgrowth and dental alveolar alterations: Possible mechanisms of cyclosporin-induced tooth migration. An experimental study in the rat. J Periodontol 1997; 68: 1231-1236.

17. Fu E, NielS, Wikesjö ME: The effect of plaque retention an cyclosporin-induced gingival overgrowth in rats. J Periodontol 1997; 68: 92-98.

18. Hall WB: Prevention of dilantin hyperplasia: A preliminary report. Bull Acad Gen Dent 1969; 20.

19. Hancock RH, Swan RH: Nifedipine-Induced gingival overgrowth. J Clin Periodontol 1992; 19: 12-14.

20. Hancock RM, Seymour RA, Rice N: The prevalence and severity of cyclosporine and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993; 20: 37-40.

21. Hassel TM, Hefti AF: Drug induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol Med 1991 ; 2: 103-137.

22. Hassel TM, Romberg E, Sobhani S, Lesko L, Douglas R: Lymphocyte-mediated effects of cyclosporine on human fibroblasts. Transpl Proc 1988; 20: 993-1002.

23. Hernández G, Arriba L, Luca M, De Andrés A: Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin-A with tarcolimus. J Periodontol 2000; 71:1630-1636.

24. Kantraci A, Cebeci I, Tuncer Ö, Carin M, Firatli E: Clinical effects of periodontal therapy on the severity of cyclosporin-A-induced gingival hyperplasia. J Periodontol 1999; 70: 587-593.

25. Kaufmann Y, Chang AE, Robb RJ, Rosenberg A: Mechanism of cyclosporin A: Inhibition of lymphokine secretion studied with antigen stimulated T cell hybridomas. J Immunol 1984; 133:3107-3111.

26. Khocht A, Schneider LC: Periodontal management of gingival overgrowth in the heart transplant patient: A case report. J Periodontol 1997; 68: 1140-1146.

27. Kimball OP: The treatment of epilepsy with sodium-diphenylhydantoinate. J Am Med Assoc 1939; 112: 1244-1245.

28. LACOPINO AM, DOXEY D, Cutler CW, NARES S, STOEVER K, Fojt J, Gonzales A, Dill RE: Phenytoin and cyclosporin-A specifically regulate macrophage phenotype and expression of plateletderived growth factor and interleukin-1 in vitro and in vivo possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997; 68: 73-83.

29. McCauley LK, RosolTJ, Capen CC: Effect of cyclosporin-A on rat osteoblasts (ROS 17/2.8 cells) in vitro. Calcif Tissue Int 1992; 51: 291-297.

30. McGawT, LamS, Coates J: Cyclosporin -induced gingival overgrowth: Correlation with dental plaque scores, gingival scores and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol '\ 987] 64: 293297.

31. McGaw WT, Porter H: Cyclosporin-induced gingival overgrowth: An ultrastructural stereoligic study. Oral Surg Oral Med Oral Pathol 1988; 65: 186-190.

32. MORISAKI I, KATO K, Loyola-Rodriguez JP, NAGATAT, ISCHIDA H: Nifedipie-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. J Periodontal Res 1993; 28: 396-403.

33. Morton RS, Dongari-Bagtzoglou AI: Regulation of gingival fibroblast interleukin-6 secretion by Cyclosporin-A. J Periodontol 1999; 70: 1464-1471.

34. Myrilas TT, Liden GJ, Marley JJ, Irvin CR: Cyclosporin-A regulates interleukin 1B and interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol 1999; 70: 294-300.

35. Nares S, Ng MC, Dill RE, Cultler CW, Iacopino AM: Cyclosporine-A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996; 67: 271-278.

36. NisikawaSJ, TadaH, Hamasaki A, etal: Nifedipine-induced gingival hyperplasia: A clinical and in vitro study. J Periodontol 1991 ; 62: 30-35.

37. Nuki K, Cooper SH: The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphenylhydantoin sodium in cats. J Periodontol Res 1972; 7: 102-110.

38. ODLUM O: Prevalence, severity and contributing factors for cyclosporin-induced gingival hyperplasia. J Dent Res 1986; 65 (Spec. Issue) 740 (Abstr.133).

39. Oettinger-Barak O, Machtei EE, Peled M, Barak S, Naaj IA, Läufer D: Cyclosporine A-induced gingival hyperplasia pemphigus vulgaris: Literature review and report of a case. J Periodontol 2000; 71: 650-656.

40. Oyer PE, Stinson EB, Jamieson SW, et al.: Cyclosporin A in cardiac allografting: A preliminary experience. Transpl Proc 1983; 15: 1247-1252.

41. Pan WL, Chan CP, Huang CC, Lai MK: Cyclosporin-induced gingival overgrowth. Transplant Proc 1992; 24: 1393-1394.

42. Pernu HE, Pernu LMH, Huttunen KRH, Nieminen PA, Knuutila MLE: Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63: 548-553.

43. Pilatti GL, Sampaio JEC: The influence of chlorhexidine on the severity of cyclosporin A-induced qinqival overgrowth. J Periodontol 1997; 68: 900-904.

44. Pilloni A, Camargo PM, Carera M, Carranza FA: Surgical treatment of cyclosporine A and Nifedipne-induced gingival enlargement: Gingivectomy versus periodontal flap. J Periodontol 1998; 69: 791-797.

45. Rateitschak-Pluss EM, Hefti A, Lôtscher R, Theil G: Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983; 10: 237-246.

46. Rostock MH, Fry HR, Turner JE: Severe gingival overgrowth associated with cyclosporin therapy. J Periodontol 1986; 57: 294-299.

47. Saravia ME, Svirsky JA, Friedman R: Chlorhexidine as an oral hygiene adjunct for cyclosporin-induced gingival hyperplasia. J Dent Child 1990; 57: 366-370.